112 related articles for article (PubMed ID: 37953563)
1. Long non-coding RNA NEAT1 inhibits high glucose-induced EMT and renal fibrogenesis in Human Embryonic Kidney 293 cells via regulating miR-204/SOX4 axis.
Ahmad Wadaan M; Ahmad M; Hussein Hamzah I
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):189-194. PubMed ID: 37953563
[TBL] [Abstract][Full Text] [Related]
2. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NEAT1 accelerates renal tubular epithelial cell damage by modulating mitophagy via miR-150-5p-DRP1 axis in diabetic nephropathy.
Yang DY; Zhou X; Liu ZW; Xu XQ; Liu C
Exp Physiol; 2021 Jul; 106(7):1631-1642. PubMed ID: 33914383
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c.
Li N; Jia T; Li YR
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1325-1337. PubMed ID: 32096162
[TBL] [Abstract][Full Text] [Related]
6. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
Gao BH; Wu H; Wang X; Ji LL; Chen C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1 Accelerates the Proliferation, Oxidative Stress, Inflammation, and Fibrosis and Suppresses the Apoptosis Through the miR-423-5p/GLIPR2 Axis in Diabetic Nephropathy.
Wu X; Fan D; Chen B
J Cardiovasc Pharmacol; 2022 Mar; 79(3):342-354. PubMed ID: 34803150
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG14 silencing attenuates the progression of diabetic nephropathy via the miR-30e-5p/SOX4 axis.
Wang Y; Yang J; Wu C; Guo Y; Ding Y; Zou X
J Diabetes; 2024 Jun; 16(6):e13565. PubMed ID: 38751373
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
Gao J; Wang W; Wang F; Guo C
Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
[TBL] [Abstract][Full Text] [Related]
10.
Yang Y; Zhou J; Li WH; Zhou ZX; Xia XB
PeerJ; 2021; 9():e11817. PubMed ID: 34386303
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA NEAT1 Regulates Pyroptosis in Diabetic Nephropathy via Mediating the miR-34c/NLRP3 Axis.
Zhan JF; Huang HW; Huang C; Hu LL; Xu WW
Kidney Blood Press Res; 2020; 45(4):589-602. PubMed ID: 32721950
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
Liu B; Qiang L; Wang GD; Duan Q; Liu J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
[TBL] [Abstract][Full Text] [Related]
14. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
15. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
16. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
Fu JX; Sun GQ; Wang HL; Jiang HX
J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
[TBL] [Abstract][Full Text] [Related]
17. Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4.
Yuan LY; Zhou M; Lv H; Qin X; Zhou J; Mao X; Li X; Xu Y; Liu Y; Xing H
J Cell Physiol; 2019 Aug; 234(10):18985-18993. PubMed ID: 30932200
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TTC28-AS1 attenuates high glucose-induced damage in HK-2 cells depending on the regulation of miR-320a/CD2AP axis.
Zhang J; Ding J; Yu M; Li F; Zhou X; Shuai H
Genes Genomics; 2021 Dec; 43(12):1471-1482. PubMed ID: 34623609
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy.
Wang J; Zhao SM
Life Sci; 2021 Jan; 264():118728. PubMed ID: 33160992
[TBL] [Abstract][Full Text] [Related]
20. Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway.
Yang H; Wang J; Zhang Z; Peng R; Lv D; Liu H; Sun Y
Front Endocrinol (Lausanne); 2021; 12():690784. PubMed ID: 34512545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
